Infraredx, Inc.

Infraredx, Inc., a subsidiary of NIPRO Corporation, is a vascular imaging company specializing in intravascular diagnostic systems. The company develops and markets advanced intravascular ultrasound (IVUS) and near-infrared spectroscopy (NIRS) imaging platforms for coronary and peripheral vascular applications. Primary products include Makoto®, a combined intravascular imaging platform that integrates high-resolution structural imaging with plaque compositional analysis for treatment planning; Clarispro® HD-IVUS, a high-definition vessel structure visualization system; and Dualpro® IVUS+ NIRS, which identifies unstable lipid-core plaques associated with major adverse cardiac events. The company also provides essential accessories including the GM-30 and NIPRO OKAY II systems. These solutions are designed for use in catheterization laboratories and interventional cardiology procedures. Infraredx serves interventional cardiologists and vascular specialists seeking advanced diagnostic capabilities for atherosclerotic disease assessment and treatment guidance. The company operates as part of NIPRO Corporation's U.S. vascular division, with organizational consolidation of U.S. subsidiaries effective April 1, 2026.